Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-28

FDA Approved: ASPRUZYO SPRINKLE — Original Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)

View source ↗

Summary

The FDA approved ASPRUZYO SPRINKLE (ranolazine) from Sun Pharmaceutical Industries under an original NDA, introducing a sprinkle formulation for the treatment o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASPRUZYO SPRINKLE (ranolazine)

Snippet

ORIG AP for ASPRUZYO SPRINKLE (RANOLAZINE)